The in vitro activity of daptomycin against 337 gram-positive European clinical isolates with known resistance genes was determined. The MIC ranges for Staphylococcus aureus, enterococci, pneunococci, and streptococci were 0.03 to 1, 0.25 to 8, 0.12 to 1, and 0.06 to 8 g/ml, respectively. For only one streptococcus isolate and seven enterococcus isolates was the MIC 8 g/ml.
with MICs at which 50 and 90% of the isolates tested are inhibited (MIC 50 and MIC 90 , respectively) of 0.25 and 0.5 g/ml, respectively. Four types of amino acid changes were detected in the quinolone resistance-determining region of grlA/gyrA of 49 S. aureus isolates. The MIC range for daptomycin against these resistant isolates was 0.06 to 0.5 g/ml (Table 1) .
A tetracycline-resistant phenotype in S. aureus was caused by the presence of either tetK (n ϭ 18), tetM (n ϭ 18), or both genes (n ϭ 7). The MIC ranges of daptomycin for these isolates were 0.06 to 1, 0.06 to 0.25, and 0.12 to 0.5 g/ml, respectively (Table 1) .
Seven Enterococcus faecalis and 27 Enterococcus faecium vanA-positive isolates were tested for sensitivity to a number of antibiotics ( Table 1 ). The MICs for daptomycin ranged from 0.5 to 4 g/ml for E. faecalis and from 0.25 to 8 g/ml for E. faecium; the MIC 50 s for these species were 0.5 and 4 g/ml, respectively; and the MIC 90 was 4 g/ml for both species.
A total of 32 E. faecalis and 16 E. faecium isolates exhibited high-level gentamicin resistance. The daptomycin MICs ranged from 0.5 to 8 g/ml for both species (Table 1) ; the MIC 50 s for E. faecalis and E. faecium were 2 and 4 g/ml, respectively; and the MIC 90 s were 2 and 8 g/ml, respectively.
In this study, daptomycin MICs for E. faecium appeared slightly higher than those in other published data. A recent study reported MIC 50 s and MIC 90 s of 2 g/ml for 25 E. faecium isolates (both vancomycin resistant and susceptible) at physiologic calcium concentrations (50 g/ml) (22) . One explanation for these results may be the limited number of isolates tested in our study.
The MICs of daptomycin and other antibiotics were determined for pneumococci with known resistance mechanisms for fluoroquinolones, tetracycline, clindamycin, and erythromycin. Two fluoroquinolone-susceptible isolates lacking amino acid changes in GyrA, ParC, GyrB, or ParE were tested, and for both, the daptomycin MIC was 0.12 g/ml (Table 1) .
Twenty isolates, categorized into four different groups according to amino acid changes associated with quinolone resistance, were tested for activity against a number of antibiotics ( Table 1 ). The daptomycin MICs for the 20 isolates ranged from 0.12 to 1 g/ml, and the MIC 50 s and MIC 90 s were 0.12 and 0.25 g/ml, respectively. The S. pneumoniae isolates were divided into five groups based on the presence of tetracycline and erythromycin/clindamycin resistance determinants ( Table 1 ). The lowest daptomycin MIC obtained in four of the five groups of isolates was 0.12 g/ml; the tetM mefE group had the lowest MIC, 0.06 g/ ml. The highest daptomycin MIC obtained in the five groups was 1.0 g/ml for isolates with tetM, compared with 0.12 g/ml for ermB-containing isolates or 0.25 g/ml for isolates in the remaining three groups.
Daptomycin and a number of comparator agents were tested for activity in 12 Streptococcus mitis and four Streptococcus sanguis isolates containing an assortment of different amino acid changes associated with quinolone resistance (Table 1) . The daptomycin MICs ranged from 0.25 to 8 g/ml. The daptomycin MIC of 8 g/ml occurred with a single S. mitis isolate and was somewhat higher than what was observed in other streptococcal species.
The activities of daptomycin and three additional antibiotics were tested in eight streptococcal species (n ϭ 46) with different clindamycin and/or erythromycin resistance-encoding genes ( Table 1 ). The daptomycin MICs ranged from 0.03 to 2 g/ml. No major differences were observed between streptococcal isolates with characterized resistance determinants, with the exception of a single fluoroquinolone-resistant S. mitis isolate.
The results were generally comparable with other data on European and North American antibiotic-resistant clinical isolates that were phenotypically but not genetically characterized (3, 8, 12, 16, 21) .
The Food and Drug Administration has defined susceptibility interpretive criteria for the approved indications. Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus dysgalactiae subsp. equisimilis isolates as well as all S. aureus isolates are susceptible to a MIC of Յ1 g/ml, whereas vancomycin-susceptible E. faecalis are susceptible to MICs of Յ4 g/ml. Based on these breakpoints, all isolates belonging to these species tested were susceptible to daptomycin. Furthermore, daptomycin also shows excellent activity against the other resistant gram-positive isolates.
In conclusion, daptomycin exhibits broad in vitro activity against a wide range of antibiotic-resistant, gram-positive pathogens containing different resistance determinants.
